Krane Funds Advisors LLC Bristol Myers Squibb CO Transaction History

Krane Funds Advisors LLC

  • $2.45 Billion
  • Q3 2024

A detailed history of Krane Funds Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Krane Funds Advisors LLC holds 10,753 shares of BMY stock, worth $621,093. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,753
Previous 556 1833.99%
Holding current value
$621,093
Previous $28,000 1885.71%
% of portfolio
0.02%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
BUY
$39.66 - $51.75 $404,413 - $527,694
10,197 Added 1833.99%
10,753 $556,000
Q3 2024

Oct 16, 2024
SELL
$39.66 - $51.75 $371,534 - $484,794
-9,368 Reduced 94.4%
556 $28,000
Q2 2024

Aug 08, 2024
SELL
$40.25 - $52.99 $20,205 - $26,600
-502 Reduced 4.81%
9,924 $412,000
Q1 2024

Apr 16, 2024
BUY
$47.98 - $54.4 $241,723 - $274,067
5,038 Added 93.5%
10,426 $565,000
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $209,918 - $250,490
-4,330 Reduced 44.56%
5,388 $276,000
Q3 2023

Nov 13, 2023
BUY
$57.89 - $64.73 $46,022 - $51,460
795 Added 8.91%
9,718 $564,000
Q2 2023

Aug 11, 2023
BUY
$63.71 - $70.74 $14,525 - $16,128
228 Added 2.62%
8,923 $571,000
Q1 2023

May 12, 2023
SELL
$65.71 - $74.53 $12,024 - $13,638
-183 Reduced 2.06%
8,695 $609,000
Q4 2022

Feb 10, 2023
SELL
$68.48 - $81.09 $101,966 - $120,743
-1,489 Reduced 14.36%
8,878 $639,000
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $14 - $8,452
-110 Reduced 1.05%
10,367 $737,000
Q2 2022

Aug 11, 2022
SELL
$72.62 - $79.98 $225,993 - $248,897
-3,112 Reduced 22.9%
10,477 $807,000
Q1 2022

May 11, 2022
BUY
$61.48 - $73.72 $439,151 - $526,581
7,143 Added 110.81%
13,589 $992,000
Q4 2021

Feb 10, 2022
SELL
$53.63 - $62.52 $43,654 - $50,891
-814 Reduced 11.21%
6,446 $402,000
Q3 2021

Nov 12, 2021
SELL
$59.17 - $69.31 $617,498 - $723,319
-10,436 Reduced 58.97%
7,260 $430,000
Q2 2021

Aug 12, 2021
BUY
$61.91 - $67.42 $724,408 - $788,881
11,701 Added 195.18%
17,696 $1.18 Million
Q1 2021

May 14, 2021
SELL
$59.34 - $66.74 $271,421 - $305,268
-4,574 Reduced 43.28%
5,995 $378,000
Q4 2020

Feb 11, 2021
BUY
$57.74 - $65.43 $235,579 - $266,954
4,080 Added 62.88%
10,569 $656,000
Q3 2020

Nov 13, 2020
SELL
$57.43 - $63.64 $9,073 - $10,055
-158 Reduced 2.38%
6,489 $391,000
Q2 2020

Aug 10, 2020
SELL
$54.82 - $64.09 $80,695 - $94,340
-1,472 Reduced 18.13%
6,647 $391,000
Q1 2020

May 12, 2020
SELL
$46.4 - $67.43 $35,403 - $51,449
-763 Reduced 8.59%
8,119 $453,000
Q4 2019

Feb 10, 2020
BUY
$49.21 - $64.19 $437,083 - $570,135
8,882 New
8,882 $570,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Krane Funds Advisors LLC Portfolio

Follow Krane Funds Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krane Funds Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krane Funds Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email